MedPath

Digital Health Intervention Based on Artificial Intelligence to Support the Personalized Recovery of Long COVID Patients Affected by Fatigue (AIDA)

Not Applicable
Completed
Conditions
Post Acute COVID-19 Syndrome
Interventions
Behavioral: Adhera® Fatigue for Long COVID program
Registration Number
NCT05483829
Lead Sponsor
Adhera Health, Inc.
Brief Summary

The AIDA feasibility study builds upon mental health and technology acceptance theoretical frameworks. It examines the feasibility of a mobile-based digital program to support patients with long covid affected by fatigue. The program Adhera ® Fatigue Self-management is adapted for long covid patients.

Detailed Description

The study will explore the usability and engagement of a digital program designed for long covid patients affected by fatigue. The digital program relies on the Adhera® personalized digital health solution that includes personalized patient education and support, monitoring using psychometrics and wearables, and mental wellbeing exercises. The patients access the mobile solution via a mobile app. A total of 15 patients will be recruited and use the mobile solution for one month.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Legal adults (older than 18)

  • Long COVID diagnosis within the last year

  • In possession of a compatible smartphone (Android OS v4.4 or higher)

  • Reporting any of these symptoms:

    • Fatigue
    • Dyspnea
    • Anxiety
    • Stress
    • Depression
    • Sleep disorder
Exclusion Criteria
  • Hospital admission during follow-up due to pathology not related to COVID-19
  • Patients without digital literacy or who cannot use the mobile application.
  • Known severe psychiatric illness or cognitive impairment
  • Being pregnant (or suspected to be pregnant)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Long COVID prospective groupAdhera® Fatigue for Long COVID program-
Primary Outcome Measures
NameTimeMethod
Behavioral outcome: UsabilityAt week 4

mHealth solution usability assessed with the System Usability Scale (SUS) questionnaire. SUS can range between 0 and 100 scores, with higher values representing higher usability.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gerencia Territorial de la Catalunya Central - Institut Catala de la Salut

🇪🇸

Sant Fruitós De Bages, Catalonia, Spain

© Copyright 2025. All Rights Reserved by MedPath